UPDATED Apr 20, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
HLF | US$8.84 | 9.1% | -40.6% | US$882.1m | US$12.50 | PE6.2x | E31.4% | 0% | ||
USNA | US$44.13 | 0.4% | -32.2% | US$849.1m | US$56.50 | PE13.3x | E-3.0% | n/a | ||
JWEL | CA$26.16 | -0.5% | -21.3% | CA$1.1b | CA$35.05 | PE22.6x | S9.9% | 2.9% | ||
WALD | US$5.46 | -12.9% | -39.7% | US$667.0m | US$10.00 | PS2.4x | E169.6% | n/a | ||
NUS | US$13.01 | 8.0% | -68.6% | US$646.1m | US$15.50 | PE75.2x | E74.1% | 1.8% | ||
GLAS.F | US$8.65 | 0.03% | 198.4% | US$617.3m | US$9.50 | PS3.8x | S28.8% | n/a | ||
THRN | US$10.19 | 0.1% | 128.5% | US$550.6m | US$8.60 | PE27.1x | E57.2% | n/a | ||
ODC | US$69.06 | 0.04% | 56.4% | US$503.2m | n/a | PE12.2x | n/a | 1.7% | ||
PZC | UK£0.90 | 5.0% | -55.4% | UK£378.0m | UK£1.56 | PB1.3x | E78.5% | 5.8% | ||
W7L | UK£4.48 | 5.3% | 126.6% | UK£345.7m | UK£550.00 | PE41.6x | E20.4% | 1.7% | ||
YSG | US$3.75 | 24.6% | -27.2% | US$403.9m | US$4.35 | PB0.7x | E120.5% | n/a | ||
SKIN | US$3.27 | -10.7% | -74.8% | US$403.7m | US$4.49 | PS1x | E122.9% | n/a | ||
NATR | US$19.29 | 1.4% | 77.3% | US$363.0m | US$24.00 | PE24.1x | E10.8% | 0% | ||
MED | US$32.44 | 3.0% | -66.3% | US$349.8m | US$37.50 | PE3.5x | E-63.2% | 0% | ||
HNST | US$3.03 | -6.8% | 68.8% | US$294.0m | US$4.55 | PB2.4x | E69.3% | n/a | ||
AAWH.U | US$1.28 | 4.9% | 48.8% | US$272.0m | US$3.41 | PB1.9x | E86.1% | n/a | ||
MCB | UK£1.01 | -4.7% | 253.8% | UK£175.8m | UK£1.16 | PE9.8x | E14.0% | 0% | ||
RSCI | US$1.03 | 41.5% | n/a | US$211.0m | n/a | n/a | n/a | n/a | ||
VERU | US$1.31 | -13.8% | -7.1% | US$191.8m | US$3.33 | PS12x | E1.7% | 0% | ||
ACRL | UK£0.39 | -3.0% | 21.0% | UK£123.1m | n/a | PB1.6x | S0.4% | 0% | ||
FTLF | US$28.87 | 2.4% | 69.8% | US$132.8m | n/a | PE25.1x | n/a | n/a | ||
OBCI | US$13.03 | 0.4% | 16.1% | US$123.9m | n/a | PE25.4x | n/a | 1.2% | ||
REVB | UK£0.31 | -7.1% | n/a | UK£98.4m | n/a | PE-5x | E118.2% | n/a | ||
BHSC | CA$0.26 | 0% | 0% | CA$143.5m | n/a | PS9.9x | n/a | n/a |